Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study

OBJECTIVE: Once-weekly PEGylated recombinant human growth hormone (rhGH) is the sole long-acting GH formulation available currently for pediatric patients with GH deficiency (GHD). The aim of this study was to evaluate the efficacy and safety of PEGylated rhGH therapy compared to daily rhGH therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yu, Wang, Zengmin, Han, Jinyan, Li, Guimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770346/
https://www.ncbi.nlm.nih.gov/pubmed/31641350
http://dx.doi.org/10.1155/2019/1438723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770346/
https://www.ncbi.nlm.nih.gov/pubmed/31641350
http://dx.doi.org/10.1155/2019/1438723

Ejemplares similares